Australian brain cancer researcher Richard Scolyer dies at 59 after a prolonged battle with brain cancer, according to multiple reports. The Conversation and The West Australian both describe him as a pioneering figure in the field and note that his work and personal experience contribute to advances in treatment. Both sources say he became widely known for volunteering for a world-first experimental treatment for brain cancer, an approach that drew global attention and was intended to help expand scientific knowledge and inform care for future patients. The Conversation reports that he died on Sunday night, while The West Australian describes his death after a long illness and frames his fight as part of a broader effort to benefit patients beyond himself. While the sources differ mainly in emphasis—one focusing on the uniqueness of his research legacy and the other on the impact of his long battle and contributions—the overall account is consistent that Scolyer was a leading researcher whose participation in experimental care helped drive knowledge in brain cancer treatment.